Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Yildirim (Eskisehir, Turkey), A. Güler (Eskisehir, Turkey), F. Alatas (Eskisehir, Turkey), S. Erginel (Eskisehir, Turkey), A. Kayikci (Eskisehir, Turkey), T. Yüce (Eskisehir, Turkey). Latent tuberculosis assessment before biological agent use. 2814

Member's Comments

No comment yet.

Related content which might interest you: Latent tuberculosis: diagnostic and treatment Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Latent tuberculosis infection: a new paradigm Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019 Latent tuberculosis infection in a drug treatment centre Source: Eur Respir J 2002; 20: Suppl. 38, 366s Year: 2002 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Cost-effectiveness of two latent tuberculosis infection screening strategies Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources Source: Eur Respir J 2006; 28: Suppl. 50, 28s Year: 2006 Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB Source: Eur Respir Mon 2012; 58: 1-13 Year: 2012 New immunologic tools for the diagnosis and therapy of tuberculosis Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Cost-optimisation of screening for latent tuberculosis in close contacts Source: Eur Respir J 2006; 28: 35-44 Year: 2006 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Extrapulmonary tuberculosis and simultaneous tuberculosis – possible indices for general population‘s health evaluation Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 The effect of tobacco smoking on drug sensitivity and microbiological characteristics of Mycobacterium tuberculosis (MTB): clinical and experimental study Source: Eur Respir J 2003; 22: Suppl. 45, 158s Year: 2003 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015 Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis Source: Eur Respir J , 49 (4)  1602215; DOI: 10.1183/13993003.02215-2016 Year: 2017 Considerations upon the drug resistance spectrum of Mycobacterium tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001